Gilead Sciences, Inc. (GILD)
US listed
This page tracks Gilead Sciences, Inc. (GILD) with live price data, technical indicators (RSI, MACD, moving averages, Sharpe ratio), and AI-powered analysis. Our scanner continuously reviews GILD against ~5,000 North American equities — fusing market fundamentals with frontier AI to surface high-conviction opportunities before they break out.
New to these indicators? RSI, MACD, and moving averages explained — plus how AI forecasting works.
Latest AI Analysis
Updated Jun 30, 202668% confidenceGilead received a significant FDA approval for Trodelvy as a first-line TNBC treatment (plus European approval), a meaningful clinical and commercial milestone that expands the addressable market and strengthens the oncology pipeline narrative. The price action over the past 10 trading days confirms this catalyst is driving a sharp momentum surge (from ~$121 to ~$141), and the stock's low beta (0.36) provides defensive insulation in the current fearful market tape. Despite a modest composite pre-screen score (1.08/10) driven by a weak trailing Sharpe and low CAGR — metrics that reflect the period before this catalyst — the forward-looking fundamental shift from the FDA approval, strong EPS growth (55.5% TTM), and reasonable valuation (P/E 16.97) support confirming a BUY on the catalyst-driven breakout.
AI recommendation: BUY · price target $148.00
GILD — Frequently Asked Questions
Is Gilead Sciences, Inc. (GILD) a buy right now?
As of June 30, 2026, StockTracker AI's screen flags GILD as BUY, with a 68% confidence, based on its multi-factor technical screen and AI review. This is a technical screen and informational analysis, not financial advice or a recommendation to trade — confirm it against your own research and risk tolerance.
What is the AI price forecast for GILD?
StockTracker AI generates a probability-weighted 30-day price forecast for GILD — a mathematical baseline (regression on recent prices) adjusted by an AI model for news, earnings proximity, and the current macro regime, with bull/base/bear scenarios. Sign in to generate the latest forecast.
How does StockTracker AI analyze GILD?
Each scan screens GILD on momentum, RSI, MACD, moving-average posture, Sharpe ratio, and 1-year CAGR to build a composite score, then a frontier AI model reviews the full picture — fundamentals, macro context, and recent news — to confirm or challenge the signal before it's surfaced.
Get the full picture for GILD — free.
Add GILD to a watchlist for instant scanner alerts. Run an on-demand 30-day AI price forecast. See the full historical signal track record. Free tier, no credit card.
Related stocks
Get scanner alerts and AI forecasts for GILD
Free tier includes daily AI recommendations, charts with indicators, and a 3-stock watchlist. No credit card.
Get Started →